Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain.

Despite a growing body of evidence that Vitamin D is involved in mammalian brain functioning, there has been a lack of direct evidence about its role in the human brain. This paper reports, for the first time, the distribution of the 1,25-dihydroxyvitamin D3 receptor (VDR), and 1alpha-hydroxylase (1alpha-OHase), the enzyme responsible for the formation of the active vitamin in the human brain. The receptor and the enzyme were found in both neurons and glial cells in a regional and layer-specific pattern. The VDR was restricted to the nucleus whilst 1alpha-OHase was distributed throughout the cytoplasm. The distribution of the VDR in human brain was strikingly similar to that reported in rodents. Many regions contained equivalent amounts of both the VDR and 1alpha-OHase, however the macrocellular cells within the nucleus basalis of Meynert (NBM) and the Purkinje cells in the cerebellum expressed 1alpha-OHase in the absence of VDR. The strongest immunohistochemical staining for both the receptor and enzyme was in the hypothalamus and in the large (presumably dopaminergic) neurons within the substantia nigra. The observed distribution of the VDR is consistent with the proposal that Vitamin D operates in a similar fashion to the known neurosteroids. The widespread distribution of 1alpha-OHase and the VDR suggests that Vitamin D may have autocrine/paracrine properties in the human brain.

[1]  H. Koeffler,et al.  Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells , 1996, Clinical & Experimental Metastasis.

[2]  D. Zehnder,et al.  Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. , 2004, Molecular and cellular endocrinology.

[3]  A. Mackay-Sim,et al.  Schizophrenia, vitamin D, and brain development. , 2004, International review of neurobiology.

[4]  D. Eyles,et al.  Vitamin D receptor expression in the embryonic rat brain , 2003 .

[5]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[6]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[7]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[8]  A. Mackay-Sim,et al.  The neurodevelopmental hypothesis of schizophrenia: a review of recent developments , 2003, Annals of medicine.

[9]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[10]  J. McGrath,et al.  Vitamin D: the neglected neurosteroid? , 2001, Trends in Neurosciences.

[11]  G. Jirikowski,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  G. Panzica,et al.  Steroids in the nervous system: a Pandora's box? , 2001, Trends in Neurosciences.

[13]  R. Kumar,et al.  Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. McGrath,et al.  Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? , 2001, Medical hypotheses.

[15]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[16]  P M Stewart,et al.  Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. , 2001, The Journal of clinical endocrinology and metabolism.

[17]  S. Kikuchi,et al.  Effect of 1,25‐dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L‐buthionine sulfoximine and 1‐methyl‐4‐phenylpyridine , 2000, Journal of neuroscience research.

[18]  T. Hayashi,et al.  Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.

[19]  F. Holsboer,et al.  Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives , 1999, Trends in Neurosciences.

[20]  W. Staines,et al.  Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[22]  M. Miller,et al.  A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. , 1999, Diabetologia.

[23]  D. Zehnder,et al.  The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase. , 1999, Molecular and cellular endocrinology.

[24]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[25]  S. Brimijoin,et al.  1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.

[26]  H. Zakon The effects of steroid hormones on electrical activity of excitable cells , 1998, Trends in Neurosciences.

[27]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. , 1998, Journal of neuroscience research.

[28]  W. Miller,et al.  Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.

[29]  G. Jirikowski,et al.  1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. , 1997, Cellular and molecular biology.

[30]  J. Barsony,et al.  Subcellular Distribution of Normal and Mutant Vitamin D Receptors in Living Cells , 1997, The Journal of Biological Chemistry.

[31]  D. Feldman,et al.  Vitamin D in the nervous system: actions and therapeutic potential. , 1997 .

[32]  D. Feldman,et al.  1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs. , 1997, Endocrinology.

[33]  E. Stachowiak,et al.  Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. , 1996, Brain research. Molecular brain research.

[34]  S. Christakos,et al.  Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. , 1995, Molecular endocrinology.

[35]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.

[36]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[37]  S. Carswell,et al.  Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.

[38]  E. Ritz,et al.  1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. , 1993, Blood.

[39]  H. Bidmon,et al.  Vitamin d nuclear binding to neurons of the septal, substriatal and amygdaloid area in the siberian hamster (Phodopus sungorus) brain , 1992, Neuroscience.

[40]  M. Somerville,et al.  Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.

[41]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[42]  K. Haglid,et al.  Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Haussler,et al.  Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.

[44]  H. DeLuca,et al.  Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.

[45]  W. Stumpf,et al.  OH ) 2 vitamin D 3 sites of action in the brain An autoradiographic study , 2022 .